The 20 Best Cataract Doctors Near Me in Baltimore, MD

Allen O. Eghrari, M.D., M.P.H., is director of the Dana Center for Preventive Ophthalmology at the Wilmer Eye Institute and associate professor of ophthalmology at the Johns Hopkins University School of Medicine. He specializes in cornea, cataract and external eye diseases at the Wilmer Eye Institute's locations in Baltimore and Belcamp, Maryland. Dr. Eghrari treats a wide range of eye conditions, with special interest in Fuchs' dystrophy, cataract surgery, cornea transplantation including Descemet Membrane Endothelial Keratoplasty, and Ebola-associated eye disease. Dr. Eghrari received his M.D. degree from the Johns Hopkins University School of Medicine and M.P.H. from the Johns Hopkins Bloomberg School of Public Health. He completed both residency training in ophthalmology and subspecialty fellowship in cornea and cataract surgery at the Wilmer Eye Institute. Dr. Eghrari is a recipient of the Claes Dohlman Society Fellowship Award, the ARVO/Alcon Early Career Clinician-Scientist Award, and the Research to Prevent Blindness Special Scholar Award. Dr. Eghrari is rated as a Distinguished provider by MediFind in the treatment of Cataract. His top areas of expertise are Fuchs Dystrophy, Macular Corneal Dystrophy Type 1, Cataract, Corneal Transplant, and Cataract Removal.

Ashley Behrens, M.D., is the Edward St. John Professor in Ophthalmology and chief of the comprehensive ophthalmology division at the Wilmer Eye Institute, Johns Hopkins Medicine. He specializes in the medical and surgical management of cataracts and corneal diseases, including corneal transplantation techniques for Fuchs’ dystrophy and keratoconus, as well as LASIK, PRK and refractive lens exchange. Dr. Behrens received his medical degree from the Universidad Central de Venezuela in Caracas, and completed his ophthalmology residency and fellowship training at the Francisco Risquez Hospital. He completed additional fellowships at the University of Erlangen-Nuremberg in Germany, where he obtained his German Doctorate with Magna Cum Laude Distinction, and then at the University of Southern California and the University of California, Irvine. Dr. Behrens joined the Wilmer faculty in 2003, and served as executive medical director at the King Khaled Eye Specialist Hospital (KKESH), Wilmer’s affiliate hospital in Saudi Arabia, from July 2010 through August 2014. Dr. Behrens is rated as a Distinguished provider by MediFind in the treatment of Cataract. His top areas of expertise are Interstitial Keratitis, Cataract, Optic Atrophy Type 1, Vitrectomy, and Cataract Removal.

Dr. Pradeep Ramulu is a glaucoma specialist and the director of the Wilmer Eye Institute glaucoma division. He specializes in caring for both routine and complex glaucomas, including glaucomas requiring repeat operations, glaucoma occurring in the context of corneal or retinal disease and glaucoma occurring in newborns and young children. The Sheila K. West Professor of Ophthalmology at the Wilmer Eye Institute, Dr. Ramulu grew up in suburban Chicago, and became interested in the eye during medical school, during which time he studied the genes and proteins of the eye with Dr. Jeremy Nathans. After pursuing a residency in ophthalmology and fellowship training in glaucoma, he joined Wilmer in 2006. Dr. Ramulu is rated as a Distinguished provider by MediFind in the treatment of Cataract. His top areas of expertise are Glaucoma, Ocular Hypertension (OHT), Cataract, Iridectomy, and Cataract Removal.

Michael X. Repka, M.D., M.B.A., is the David L. Guyton, M.D., and Feduniak Family Professor of Ophthalmology at the Wilmer Eye Institute. He specializes in pediatric ophthalmology, strabismus, retinopathy of prematurity and pediatric neuro-ophthalmology. His clinical practice includes an interest in the management of strabismus and amblyopia. In these areas, he has a special interest in using alternatives to patching for the management of amblyopia and using strabismus surgery, botulinum toxin and adjustable sutures to treat strabismus. He also performs cataract surgery and intraocular lens implantation on children with cataracts and has a special interest in pediatric neuro-ophthalmology involving normal and abnormal visual development and the effect of injury and tumor on the visual system of the child. Dr. Repka received his M.D. degree from Thomas Jefferson University and completed his ophthalmology residency at Wills Eye Hospital. He completed fellowships in neuro-ophthalmology and pediatric ophthalmology at the Wilmer Eye Institute and joined the faculty in 1985. In addition to his clinical responsibilities, Dr. Repka is the vice chair for clinical practice at Wilmer. Dr. Repka is the past chairman of the Pediatric Eye Disease Investigator Group and past president of the Maryland Society of Eye Physicians and Surgeons. He is medical director of Government Affairs of the American Academy of Ophthalmology. Dr. Repka is rated as a Distinguished provider by MediFind in the treatment of Cataract. His top areas of expertise are Strabismus, Brown Syndrome, Amblyopia, Cataract Removal, and Vitrectomy.

Douglas A. Jabs, M.D., M.B.A. is an internationally-recognized expert in the evaluation and management of patients with uveitis and related immune-mediated ocular disorders, particularly on the use of immunosuppression to treat severe ocular inflammatory diseases. Founder of the Division of Ocular Immunology and Uveitis at Wilmer, he now is the Director of the Center for Clinical Trials and Evidence Synthesis at the Johns Hopkins University Bloomberg School of Public Health. Dr. Jabs is rated as an Advanced provider by MediFind in the treatment of Cataract. His top areas of expertise are Uveitis, CMV Retinitis, Scleritis, Cataract Removal, and Trabeculectomy.

Meghan Berkenstock, M.D., is an associate professor of ophthalmology at the Johns Hopkins Wilmer Eye Institute. She specializes in ocular inflammatory and infectious diseases, cataract surgery, and comprehensive ophthalmology. Since joining the faculty of the Wilmer Eye Institute in 2016, she has established a research focus on risk reduction and quality assurance initiatives in the care of patients with uveitis. She has implemented several initiatives to improve laboratory monitoring and understanding barriers to care in patients on immunosuppressive medications. The bulk of her research focuses on identifying ocular adverse events (IRAE) associated with the use of immunotherapy agents in the treatment of systemic malignancies. She is a member and the only ophthalmologist on the National Comprehensive Cancer Network Panel on developing guidelines to treat IRAEs. Dr. Berkenstock is rated as an Advanced provider by MediFind in the treatment of Cataract. Her top areas of expertise are Scleritis, Episcleritis, Uveitis, Vitrectomy, and Cataract Removal.

Bryn M. Burkholder, M.D., is an assistant professor of ophthalmology at the Wilmer Eye Institute and the Antoinette R. Schifanelli Rising Professor of Ophthalmology, specializing in ocular inflammatory and infectious diseases, cataract surgery and comprehensive ophthalmology. Dr. Burkholder earned her bachelor's degree from Duke University, where she majored in biology, and received her medical degree from the University of Pennsylvania. After completing an internship at the Albert Einstein Medical Center in Philadelphia, she moved to Baltimore for her residency in ophthalmology at the Wilmer Eye Institute. Dr. Burkholder remained at Wilmer for her fellowship training in uveitis before joining the faculty in July 2012. Dr. Burkholder is rated as an Advanced provider by MediFind in the treatment of Cataract. Her top areas of expertise are Uveitis, Scleritis, Neuroretinitis, Episcleritis, and Cataract Removal.

Michael Sulewski, M.D., is the James and Heather Gills Rising Professor of Ophthalmology and a cornea and cataract specialist at the Wilmer Eye Institute’s Baltimore locations at Bayview Medical Center and the Patient Access Center for the Eye at The Johns Hopkins Hospital, as well as in White Marsh, Maryland. Dr. Sulewski is also the ophthalmology residency program director. Dr. Sulewski specializes in cataract surgery, intraocular lens complications, corneal transplantation, keratoprosthesis, refractive surgery and other medical and surgical diseases of the cornea and anterior segment of the eye. Dr. Sulewski is also a resident supervisor at the Wilmer Eye Institute Patient Center for the Eye at The Johns Hopkins Hospital. Recent News Articles and Media Coverage Five Questions for Michael Sulewski, Johns Hopkins Medicine (Dec. 2020). Dr. Sulewski is rated as an Advanced provider by MediFind in the treatment of Cataract. His top areas of expertise are Cataract, Acute Posterior Multifocal Placoid Pigment Epitheliopathy (APMPPE), Cogan's Syndrome, Interstitial Keratitis, and Cataract Removal.

Nakul Shekhawat, M.D., M.P.H. is an ophthalmologist and eye surgeon at the Johns Hopkins Wilmer Eye Institute and the 2023 Stephen F Raab and Mariellen Brickley-Raab Rising Professor of Ophthalmology. He specializes in cataract surgery, complex cataract and anterior segment surgery, corneal and external diseases, and corneal surgery including both full- and partial-thickness corneal transplantation (DMEK, DSAEK, DALK, PKP). Dr. Shekhawat received his M.D. degree from Vanderbilt University School of Medicine and his M.P.H. degree in epidemiology and biostatistics from the Johns Hopkins Bloomberg School of Public Health. He completed ophthalmology residency at the renowned Kellogg Eye Center, University of Michigan where he received the Resident Excellence Award from the American Society of Cataract and Refractive Surgery. He completed additional subspecialty training in cornea, external disease, and refractive surgery at the Wilmer Eye Institute where he was awarded the prestigious Claes Dohlman Award from Harvard Medical School recognizing the most outstanding cornea fellow in the country. CV https://www.hopkinsmedicine.org/-/media/wilmer/documents/cvs/Shekhawat_CV.pdf Recent News Articles and Media Coverage Laser cataract surgery now offered in Bethesda- Hopkins Medicine (April 2024) Johns Hopkins, Microsoft Extend Collaboration for Startups as Newest Grant Recipients Named - Johns Hopkins Technology Ventures (July 2021) Taking a Wide View with Nakul Shekhawat - Hopkins Medicine (September 2020) A Patient’s Guide to Shingles: Prompt treatment is crucial to avoid severe neurological complications - US News & World Report (January 2020) Shingle White Female: Study finds three-fold increase in number of Americans diagnosed with shingles - The Ophthalmologist (July 2019). Dr. Shekhawat is rated as an Advanced provider by MediFind in the treatment of Cataract. His top areas of expertise are Interstitial Keratitis, Cataract, Amebiasis, Cataract Removal, and Vitrectomy.

Dr. Kraig Scot Bower is an associate professor of ophthalmology and the director of refractive surgery at the Wilmer Eye Institute. He specializes in refractive surgery (LASIK), cornea and external diseases of the eye and anterior segment surgery. Dr. Bower is a retired Army colonel, Medical Corps. From 2001 to 2010, he was the director of refractive surgery at Walter Reed Army Medical Center and served as the Army's refractive surgery subject matter expert, advising the Army Surgeon General on laser refractive surgery and managing the Army's Warfighter Refractive Eye Surgery Program. Dr. Bower is rated as an Advanced provider by MediFind in the treatment of Cataract. His top areas of expertise are Keratoconus, Astigmatism, Cataract, and Nearsightedness.

Samuel C. Yiu, M.D., Ph.D., is an associate professor of ophthalmology at the Wilmer Eye Institute, specializing in cornea and external eye diseases, cataracts and refractive surgery (LASIK). In addition, he is a nationally and internationally recognized specialist in ocular surface diseases and ocular surface reconstruction surgery. Dr. Yiu received his M.Sc. (applied biometry) and Ph.D. (physiology and biophysics) from the University of Southern California. He then completed a post-doctoral fellowship in lacrimal physiology at the Schepens Eye Institute at Harvard Medical School and went on to earn his M.D. from the University of Alberta in Canada. Dr. Yiu completed an internship and his ophthalmology residency at Dalhousie University in Halifax, Nova Scotia and a fellowship in cornea, external disease and refractive surgery at the University of Southern California’s Doheny Eye Institute. After serving as the director of Doheny’s Ocular Surface Center and co-director of Doheny’s cornea division, Dr. Yiu joined the Wilmer faculty in 2011 and spent two years as the chief of the cornea division at King Khaled Eye Specialist Hospital (KKESH), Wilmer’s affiliate hospital in Riyadh, Saudi Arabia, before returning to Baltimore in 2013. Dr. Yiu is rated as an Advanced provider by MediFind in the treatment of Cataract. His top areas of expertise are Cataract, Interstitial Keratitis, Dry Eye Syndrome, and Cloudy Cornea.

Basil Morgan is an Ophthalmologist in Baltimore, Maryland. Dr. Morgan is rated as an Experienced provider by MediFind in the treatment of Cataract. His top areas of expertise are Cataract, Allergic Conjunctivitis, Glaucoma, and Dry Eye Syndrome.

Thomas Johnson is an Ophthalmologist in Baltimore, Maryland. Dr. Johnson is rated as an Experienced provider by MediFind in the treatment of Cataract. His top areas of expertise are Glaucoma, Cataract, and Diabetic Retinopathy.

Dr. Neil Bressler has been a member of the Wilmer Eye Institute's faculty since 1988 and is the inaugural James P. Gills Professor of Ophthalmology. He specializes in retinal diseases, with special interests in diabetic retinopathy and macular degeneration. Dr. Bressler's main research interests have been collaborative efforts in clinical trials of common retinal diseases, including age-related macular degeneration and diabetic retinopathy, having chaired several NIH-sponsored and industry-sponsored multicenter randomized clinical trials and authored almost 300 peer-reviewed publications. He is a past chair of the NIH-sponsored Diabetic Retinopathy Clinical Research Network, and was responsible for guidelines, policies, protocol development as well as implementation, and to facilitate Network operations in a way that maintains academic integrity and optimal clinical trial performance. He also has chaired the National Eye Institutes Data and Safety Monitoring Committee for intramural clinical trials and the FDA Ophthalmic Devices Panel. Dr. Bressler is currently editor-in-chief of JAMA Ophthalmology. Dr. Bressler is rated as an Experienced provider by MediFind in the treatment of Cataract. His top areas of expertise are Diabetic Macular Edema (DME), Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Vitrectomy, and Cataract Removal.

James T. Handa, M.D., is Chief of the Retina Division and the Robert Bond Welch, M.D., Professor of Ophthalmology at the Wilmer Eye Institute. He specializes in medical and surgical management of complex vitreoretinal diseases such as age-related macular degeneration, diabetic retinopathy, retinal detachment, retinopathy of prematurity and other pediatric retinal diseases. He also has expertise in intraocular oncology and manages patients with choroidal melanomas and metastatic tumors of the eye. Not only is he a highly skilled surgeon and clinician, but he also devotes significant effort to research related to the early causes of age-related macular degeneration using molecular pathological approaches to understand how the eye transforms from normal aging to early disease. He has been funded by the National Eye Institute for the last 19 years, and he currently holds two R01 awards for his work in AMD. He has also been funded by the Thome Foundation, Research to Prevent Blindness, Fight for Sight and the American Health Assistance Foundation. His other research focuses on surgical innovation using an integrated robotic surgical system. Dr. Handa is currently the Wilmer Eye Institute’s implanting surgeon for the Argus II retinal chip implant, which was recently approved by the FDA after Dr. Handa participated in the clinical trial leading to its approval. Dr. Handa is rated as an Experienced provider by MediFind in the treatment of Cataract. His top areas of expertise are Melanoma of the Eye, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Metastatic Uveal Melanoma, and Vitrectomy.

Peter A. Campochiaro, M.D. is the George S. and Dolores Doré Eccles Professor of Ophthalmology and Neuroscience at the Wilmer Eye Institute, Johns Hopkins University School of Medicine. He is a clinician-scientist who directs a research laboratory and conducts clinical trials. His laboratory research is directed at understanding the pathogenesis of ocular neovascularization and excessive retinal vascular permeability, and the mechanism of cone cell death in inherited retinal degenerations. He helped to determine the importance of vascular endothelial growth factor (VEGF), hypoxia-inducible factor-1, and Tie2 in retinal and choroidal vascular diseases. The clinical trial group under Dr. Campochairo provided the first demonstration of the benefits of suppression of VEGF in diabetic macular edema and retinal vein occlusion. He has developed strategies for sustained suppression of VEGF that are currently being tested in clinical trials. Dr. Campochiaro trained at the University of Notre Dame, Johns Hopkins School of Medicine, and the University of Virginia. He did a vitreoretinal fellowship and research fellowships at Johns Hopkins and joined the faculty of the University of Virginia in 1984. He became professor of Ophthalmology and Neuroscience at the Wilmer Eye Institute, Johns Hopkins in 1991. Dr. Campochiaro is rated as an Experienced provider by MediFind in the treatment of Cataract. His top areas of expertise are Retinal Vein Occlusion, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Trabeculectomy, and Vitrectomy.

Bryce Chiang, M.D., Ph.D., is an assistant professor of ophthalmology and a glaucoma specialist at the Wilmer Eye Institute, Johns Hopkins Medicine East Baltimore location. His clinical interests include the medical and surgical management of glaucoma and cataract. After receiving his combined bachelor’s/master’s degrees in biomedical engineering from The Johns Hopkins University, Dr. Chiang completed joint M.D./Ph.D. degrees at the Emory University School of Medicine. During his doctorate in biomedical engineering at the Georgia Institute of Technology, Dr. Chiang became interested in ophthalmology through his research in ocular drug delivery. He served as a medicine intern at Highland Hospital in Oakland, California, and completed his ophthalmology residency, glaucoma fellowship and innovation fellowship at the Byers Eye Institute at Stanford University. Dr. Chiang’s research interests include targeted ocular drug delivery, specifically within the suprachoroidal space and to the optic nerve head. He studied the pharmacokinetics of microneedle injections into the suprachoroidal space while pursuing his doctorate at Georgia Tech, and maintains an interest in the suprachoroidal space as a means of altering disease trajectory. Furthermore, despite the optic nerve head being the site of disease in optic neuropathies, no therapies exist that treat the optic nerve head. By directly treating the diseased tissue, targeting therapeutics to the optic nerve head may enable paradigm shifting therapies for optic neuropathies. Targeted delivery to the optic nerve head may also serve as a research tool to query the pathogenesis of glaucoma. Dr. Chiang is rated as an Experienced provider by MediFind in the treatment of Cataract. His top areas of expertise are Glaucoma, Ocular Hypertension (OHT), Uveitis, and Nearsightedness.

Mustafa Iftikhar, M.D., is the Stephen J. Ryan Assistant Chief of Service and assistant professor of ophthalmology at the Wilmer Eye Institute, Johns Hopkins Medicine. Dr. Iftikhar completed his ophthalmology residency at Wilmer, followed by a vitreoretinal surgery fellowship at Duke University Hospital. His clinical approach is rooted in patient-centered and evidence-based care. Dr. Iftikhar’s research interests include retinal diseases, ocular trauma, and healthcare disparities. He is deeply committed to surgical education and takes great pride in mentoring the next generation of ophthalmologists. Dr. Iftikhar is rated as an Experienced provider by MediFind in the treatment of Cataract. His top areas of expertise are Retinopathy Pigmentary Mental Retardation, Retinitis Pigmentosa, Late-Onset Retinal Degeneration, Vitrectomy, and Trabeculectomy.

Peter L. Gehlbach, M.D., Ph.D. is the J. Willard Marriott, Jr. Professor of Ophthalmology with joint appointment in the Department of Electrical and Computer Engineering, The Whiting School of Engineering. A member of the Wilmer faculty since 2000, he was recruited by a national search to become the inaugural Maumenee Scholar at Johns Hopkins University School of Medicine. His clinical practice is composed of international, national, and regional patient populations with the most complex retinal disease. An expert vitreoretinal surgeon, Dr. Gehlbach has been a leader in performing and teaching complex surgical cases that require coordination with multiple ophthalmological specialists. His research interests include cutting-edge surgical approaches to patients with retinal disease and the development of novel surgical tools and approaches to retinal microsurgery. Dr. Gehlbach’s work has been supported by multiple NIH grants and prestigious foundations with research published in numerous peer-reviewed journals and presented at ophthalmology conferences around the world. The founding director of the former Wilmer Gene Therapy Vector Center, he has served as the director of the Wilmer Echography Center as well as the Retina Fellowship Training Program at Johns Hopkins. He holds multiple patents in both the U.S. and abroad. Dr. Gehlbach received his B.A. and M.D. degrees from the University of Vermont, and his Ph.D. in cell and integrative physiology from the University of Minnesota. He completed an internship and residency training in general surgery at the University of Health Sciences, Chicago Medical School. His ophthalmology residency was at Washington University in St. Louis, where he also completed a fellowship in protein chemistry. He completed a medical and surgical retina fellowship at the Casey Eye Institute in Portland. Dr. Gehlbach is rated as an Experienced provider by MediFind in the treatment of Cataract. His top areas of expertise are Retinal Vein Occlusion, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Retinal Detachment, and Vitrectomy.

Jonathan Ekedahl is an Ophthalmologist in Baltimore, Maryland. Dr. Ekedahl has been practicing medicine for over 18 years and is rated as a Distinguished provider by MediFind in the treatment of Cataract. His top areas of expertise are Cataract, Glaucoma, Neuroretinitis, and Conjunctivitis (Pink Eye).